Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) [Phase 2]
Phase 2 trial update describing a modular 'Basket of Baskets' platform to tailor personalized cancer treatment across multiple tumor types; …
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: A Study of BA1202 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating BA1202 in patients with solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: Merestinib In Non-Small Cell Lung Cancer And Solid Tumors [Phase 2]
Phase 2 trial update for merestinib in non-small cell lung cancer and solid tumors; study terminated with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial of repotrectinib in combination with other anticancer therapies for KRAS-mutant solid tumors has been terminated with result…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for a study evaluating safety, efficacy, and pharmacokinetics in participants with advanced solid tumors, including re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies [Phase 2]
Phase 2 trial of poziotinib in EGFR or HER2 activating mutations across advanced malignancies was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: PTX-35 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for PTX-35 in patients with advanced solid tumors; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours [Phase 1, Phase 2]
Clinical trial update for ZG2001 in KRAS-mutated advanced solid tumors in Phase 1/2 cohorts.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for intravenous T3011 as a single agent and in combination therapy in advanced solid tumors including hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating safety and tolerability of RO7296682 in participants with advanced solid tumors; study terminated with results post…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Study of GFH018 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of GFH018 in patients with advanced solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1 [Phase 2]
Phase 2 trial evaluating crizotinib in patients with ALK, MET, or ROS1 alterations has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for IAH0968 in HER2-positive advanced solid tumors spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) [Phase 2]
A Phase 2 basket trial evaluating FGFR1/2/3 fusions in solid tumors was terminated; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma [Phase 1, Phase 2]
A study investigating CYC140 in subjects with advanced solid tumors and lymphoma (Phase 1/Phase 2) is listed with unknown status.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations [Phase 2]
Phase 2 trial evaluating immunotherapy in patients with metastatic cancers harboring CDK12 mutations has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors [Phase 1, Phase 2]
Phase 1/2 first-in-human open-label dose-escalation study of a CSP-targeting functional antibody in solid tumors completed.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for HB0028 in advanced solid tumors and cervical cancer across Phase 1/Phase 2; no results data provided.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma [Phase 1, Phase 2]
Clinical trial update for Fadraciclib (CYC065) in advanced solid tumors and lymphoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Safety and Efficacy of RX-af01 Combined With PD-1 Antibody [Phase 1, Phase 2]
Early-stage trial evaluating RX-af01 in combination with a PD-1 antibody shows safety and potential efficacy signals in solid tumors; overal…
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children [Phase 3]
A Phase 3 clinical trial comparing oral disintegrating tablet ondansetron (ODF) to intravenous ondansetron for preventing chemotherapy-induc…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR) [Phase 1, Phase 2]
Phase 1/2 trial SEASTAR evaluating rucaparib in combination with other anticancer agents in solid tumors; study terminated with results post…
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma [Phase 2, Phase 3]
Phase 2/3 trial update exploring S-1 combined with DC+CIK as maintenance therapy for advanced pancreatic ductal adenocarcinoma, status curre…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial PROCLAIM-CX-2009 evaluating safe and active doses of CX-2009 for selected solid tumors; trial status terminated with results…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas [Phase 1, Phase 2]
Phase Ⅰ/Ⅱ study evaluating SHR2554 in combination with SHR1701 in advanced solid tumors and B-cell lymphomas is underway, with no current st…